2020 国际共识指南:慢性胰腺炎的危险因素

2020-04-08 国际胰腺病协会 Pancreatology. 2020 Apr 8.

慢性胰腺炎是一种严重影响生活质量的胰腺永久性损伤的复杂炎症性疾病,本文作为慢性胰腺炎国际共识的一部分,主要针对CP的危险因素提出专家共识意见。

中文标题:

2020 国际共识指南:慢性胰腺炎的危险因素

英文标题:

International Consensus Guidelines for Risk Factors in Chronic Pancreatitis

发布机构:

国际胰腺病协会

发布日期:

2020-04-08

简要介绍:

慢性胰腺炎是一种严重影响生活质量的胰腺永久性损伤的复杂炎症性疾病,本文作为慢性胰腺炎国际共识的一部分,主要针对CP的危险因素提出专家共识意见。

 

相关资料下载:
[AttachmentFileName(sort=1, fileName=2020 国际共识指南:慢性胰腺炎的危险因素.pdf)] GetToolGuiderByIdResponse(projectId=1, id=5955f1c00191069d, title=2020 国际共识指南:慢性胰腺炎的危险因素, enTitle=International Consensus Guidelines for Risk Factors in Chronic Pancreatitis, guiderFrom=Pancreatology. 2020 Apr 8., authorId=0, author=, summary=慢性胰腺炎是一种严重影响生活质量的胰腺永久性损伤的复杂炎症性疾病,本文作为慢性胰腺炎国际共识的一部分,主要针对CP的危险因素提出专家共识意见。, cover=https://img.medsci.cn/2020529/1590684449020_2020535.jpg, journalId=0, articlesId=null, associationId=682, associationName=国际胰腺病协会, associationIntro=国际胰腺病协会是一个由来自32个国家的科学家及临床工作者组成的独特的国际性组织,致力于胰腺及胰腺相关疾病的基础与临床研究以改善胰腺相关疾病的预后。期官方期刊为《Pancreatology》。, copyright=0, guiderPublishedTime=Wed Apr 08 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>慢性胰腺炎是一种严重影响生活质量的胰腺永久性损伤的复杂炎症性疾病,本文作为慢性胰腺炎国际共识的一部分,主要针对CP的危险因素提出专家共识意见。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=14127, tagName=慢性胰腺炎)], categoryList=[CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=91, categoryName=肝胆胰外科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=14127, guiderKeyword=慢性胰腺炎, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=4, opened=0, paymentType=, paymentAmount=20, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=1675, appHits=154, showAppHits=12, pcHits=484, showPcHits=1542, likes=0, shares=1, comments=10, approvalStatus=1, publishedTime=Fri May 29 01:53:36 CST 2020, publishedTimeString=2020-04-08, pcVisible=1, appVisible=1, editorId=4754896, editor=fbzhang, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=qiushida2, createdTime=Fri May 29 00:47:33 CST 2020, updatedBy=4754896, updatedName=fbzhang, updatedTime=Wed Jan 03 04:16:35 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2020 国际共识指南:慢性胰腺炎的危险因素.pdf)])
2020 国际共识指南:慢性胰腺炎的危险因素.pdf
下载请点击:
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=953167, encodeId=a33095316e65, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8bea5412914, createdName=ms8000001944200406, createdTime=Thu Apr 01 21:13:26 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=924745, encodeId=aa7a924e4550, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bbc54878704, createdName=13844ac517m, createdTime=Mon Feb 15 14:23:59 CST 2021, time=2021-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884009, encodeId=8b5a8840096c, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q3auHgzwzM6tia9pyZiaPziaeLHadUZP17uiav8DTro6peFy5lvuO5EjYrG4ButKWVynGX1CUFFBbXhib9bjE77pkHw/132, createdBy=41785253089, createdName=医路前行4231, createdTime=Wed Sep 09 22:36:35 CST 2020, time=2020-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884007, encodeId=f2b488400e7b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q3auHgzwzM6tia9pyZiaPziaeLHadUZP17uiav8DTro6peFy5lvuO5EjYrG4ButKWVynGX1CUFFBbXhib9bjE77pkHw/132, createdBy=41785253089, createdName=医路前行4231, createdTime=Wed Sep 09 22:35:56 CST 2020, time=2020-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812882, encodeId=b8d6812882b5, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201030/d4f9cda9838b4ced8e47258b7d2fa483/822ba90b8644401f8d14936df38a1720.jpg, createdBy=b0475413073, createdName=LeoQ, createdTime=Tue Aug 25 00:32:18 CST 2020, time=2020-08-25, status=1, ipAttribution=)]
    2021-04-01 ms8000001944200406

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=953167, encodeId=a33095316e65, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8bea5412914, createdName=ms8000001944200406, createdTime=Thu Apr 01 21:13:26 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=924745, encodeId=aa7a924e4550, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bbc54878704, createdName=13844ac517m, createdTime=Mon Feb 15 14:23:59 CST 2021, time=2021-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884009, encodeId=8b5a8840096c, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q3auHgzwzM6tia9pyZiaPziaeLHadUZP17uiav8DTro6peFy5lvuO5EjYrG4ButKWVynGX1CUFFBbXhib9bjE77pkHw/132, createdBy=41785253089, createdName=医路前行4231, createdTime=Wed Sep 09 22:36:35 CST 2020, time=2020-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884007, encodeId=f2b488400e7b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q3auHgzwzM6tia9pyZiaPziaeLHadUZP17uiav8DTro6peFy5lvuO5EjYrG4ButKWVynGX1CUFFBbXhib9bjE77pkHw/132, createdBy=41785253089, createdName=医路前行4231, createdTime=Wed Sep 09 22:35:56 CST 2020, time=2020-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812882, encodeId=b8d6812882b5, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201030/d4f9cda9838b4ced8e47258b7d2fa483/822ba90b8644401f8d14936df38a1720.jpg, createdBy=b0475413073, createdName=LeoQ, createdTime=Tue Aug 25 00:32:18 CST 2020, time=2020-08-25, status=1, ipAttribution=)]
    2021-02-15 13844ac517m

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=953167, encodeId=a33095316e65, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8bea5412914, createdName=ms8000001944200406, createdTime=Thu Apr 01 21:13:26 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=924745, encodeId=aa7a924e4550, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bbc54878704, createdName=13844ac517m, createdTime=Mon Feb 15 14:23:59 CST 2021, time=2021-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884009, encodeId=8b5a8840096c, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q3auHgzwzM6tia9pyZiaPziaeLHadUZP17uiav8DTro6peFy5lvuO5EjYrG4ButKWVynGX1CUFFBbXhib9bjE77pkHw/132, createdBy=41785253089, createdName=医路前行4231, createdTime=Wed Sep 09 22:36:35 CST 2020, time=2020-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884007, encodeId=f2b488400e7b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q3auHgzwzM6tia9pyZiaPziaeLHadUZP17uiav8DTro6peFy5lvuO5EjYrG4ButKWVynGX1CUFFBbXhib9bjE77pkHw/132, createdBy=41785253089, createdName=医路前行4231, createdTime=Wed Sep 09 22:35:56 CST 2020, time=2020-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812882, encodeId=b8d6812882b5, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201030/d4f9cda9838b4ced8e47258b7d2fa483/822ba90b8644401f8d14936df38a1720.jpg, createdBy=b0475413073, createdName=LeoQ, createdTime=Tue Aug 25 00:32:18 CST 2020, time=2020-08-25, status=1, ipAttribution=)]
    2020-09-09 医路前行4231

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=953167, encodeId=a33095316e65, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8bea5412914, createdName=ms8000001944200406, createdTime=Thu Apr 01 21:13:26 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=924745, encodeId=aa7a924e4550, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bbc54878704, createdName=13844ac517m, createdTime=Mon Feb 15 14:23:59 CST 2021, time=2021-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884009, encodeId=8b5a8840096c, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q3auHgzwzM6tia9pyZiaPziaeLHadUZP17uiav8DTro6peFy5lvuO5EjYrG4ButKWVynGX1CUFFBbXhib9bjE77pkHw/132, createdBy=41785253089, createdName=医路前行4231, createdTime=Wed Sep 09 22:36:35 CST 2020, time=2020-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884007, encodeId=f2b488400e7b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q3auHgzwzM6tia9pyZiaPziaeLHadUZP17uiav8DTro6peFy5lvuO5EjYrG4ButKWVynGX1CUFFBbXhib9bjE77pkHw/132, createdBy=41785253089, createdName=医路前行4231, createdTime=Wed Sep 09 22:35:56 CST 2020, time=2020-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812882, encodeId=b8d6812882b5, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201030/d4f9cda9838b4ced8e47258b7d2fa483/822ba90b8644401f8d14936df38a1720.jpg, createdBy=b0475413073, createdName=LeoQ, createdTime=Tue Aug 25 00:32:18 CST 2020, time=2020-08-25, status=1, ipAttribution=)]
    2020-09-09 医路前行4231

    学习了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=953167, encodeId=a33095316e65, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8bea5412914, createdName=ms8000001944200406, createdTime=Thu Apr 01 21:13:26 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=924745, encodeId=aa7a924e4550, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bbc54878704, createdName=13844ac517m, createdTime=Mon Feb 15 14:23:59 CST 2021, time=2021-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884009, encodeId=8b5a8840096c, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q3auHgzwzM6tia9pyZiaPziaeLHadUZP17uiav8DTro6peFy5lvuO5EjYrG4ButKWVynGX1CUFFBbXhib9bjE77pkHw/132, createdBy=41785253089, createdName=医路前行4231, createdTime=Wed Sep 09 22:36:35 CST 2020, time=2020-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884007, encodeId=f2b488400e7b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q3auHgzwzM6tia9pyZiaPziaeLHadUZP17uiav8DTro6peFy5lvuO5EjYrG4ButKWVynGX1CUFFBbXhib9bjE77pkHw/132, createdBy=41785253089, createdName=医路前行4231, createdTime=Wed Sep 09 22:35:56 CST 2020, time=2020-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812882, encodeId=b8d6812882b5, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201030/d4f9cda9838b4ced8e47258b7d2fa483/822ba90b8644401f8d14936df38a1720.jpg, createdBy=b0475413073, createdName=LeoQ, createdTime=Tue Aug 25 00:32:18 CST 2020, time=2020-08-25, status=1, ipAttribution=)]
    2020-08-25 LeoQ

    学习学习

    0

拓展阅读

2015年JSGE循证临床实践指南:慢性胰腺炎

日本胃肠病学会(JSGE,Japanese Society of Gastroenterology) · 2016-06-08

2018 IAP/APA/JPS/EPC指南:慢性胰腺炎截面影像学诊断和严重程度评分

国际胰腺病协会(IAP,International Association of Pancreatology) · 2018-08-28

2018 ESGE指南:慢性胰腺炎的内镜治疗

欧洲胃肠道内窥镜学会(ESGE,European Society of Gastrointestinal Endoscopy) · 2019-01-17

消化系统常见病慢性胰腺炎中医诊疗指南(基层医生版)

中华中医药学会外科分会 · 2019-12-26